// App-Quantinova.ai

: ATG2B/Gskip in De Novo Acute Myeloid Leukemia (AML): High Prevalence of Germline Predisposition in French West Indies and Potential Role of Overexpression in Acquired AML

Researchers

Presenter

  • Jean Pegliasco

Principal Investigators

  • Jean-Edouard Martin

  • Samy Chraibi

  • Clemence Legoupil

  • Florence Pasquier

  • Christophe Willekens

  • Odile Bera

  • Olivier Caron

  • Jean-Henri Bourhis

  • Roseline Tang

  • Adel Ben-Ali

  • Maureen Lopez

  • Sophie Cotteret

  • Veronique Saada

  • Nathalie Auger

  • Jacques Delaunay

  • Pascale Cornillet-Lefebvre

  • Christian Recher

  • Stephane de Botton

  • William Vainchenker

  • Pascal Fuseau

  • Raouf Benabelali

  • Philippe Helias

  • Christophe Marzac

  • Isabelle Plo

  • Jean-Come Meniane

  • Christine Bellann-Chantelot

  • Jean-Baptiste Micol

Medical Centers

  • Gustave Roussy, Villejuif, France

  • INSERM U1170, Institut Gustave Roussy, Villejuif, France

  • Hospital Pierre Zobda-Quitman, Fort-de-France Bay, France

  • Department of Surgery, Gustave Roussy Cancer Centre, Villejuif, France

  • Gustave Roussy, Villejuif, France

  • Clinique Le Moulin de Viry, Viry-Châtillon, France

  • Département de Biologie-Pathologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France

  • Medical Oncology, Centre Catherine de Sienne, Nantes, France

  • Hematology Biology, Reims University Hospital, Reims, France

  • Clinical Hematology, ins, Toulouse, France

  • Institut Gustave-Roussy, Villejuif, France

  • Gustave Roussy Cancer Campus, Villejuif, France

  • Laboratoire CERBA, Saint-Ouen-l'Aumône, France

  • CHU Pointe-à-Pitre/Abymes, Les Abymes, France

  • Département de Biologie-Pathologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France

  • INSERM U1170, Institut Gustave Roussy, Villejuif, France

  • Rheumatology department, CHU Fort de France, Fort de France, France

  • INSERM U1170, Institut Gustave Roussy, Villejuif, France

  • Gustave Roussy cancer center, Villejuif, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute Leukemia

  • Acute lymphoblastic leukemia

  • Myeloid neoplasms

  • Hematological malignancies

  • Myelodysplastic Syndrome

  • Acute myelocytic leukemia

  • Lymphomas

  • Solid malignancies

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Breakpoint Cluster Region

  • Calreticulin

  • DNA methyltransferase 3 alpha

  • ETV6-RUNX1

  • Tet methylcytosine dioxygenase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved